Theodor Escherich, a German-Austrian pediatrician, first described the bacterium we now call E. coli in 1885, after isolating it from the intestines of healthy newborns. What began as a clinical observation about infant digestion eventually gave rise to one of the most studied organisms in the history of science, a microbe that has shaped fields from molecular biology to synthetic genomics. The story of its discovery is inseparable from the story of modern microbiology itself.
Theodor Escherich and the Bacterium From Infant Guts
In the 1880s, infant mortality in Europe was devastatingly high, and digestive illnesses were a leading killer. Theodor Escherich, then a young physician in Munich, set out to understand the microbial world inside the intestines of newborns and breastfed infants. His approach was painstaking: he cultured bacteria from stool samples and carefully catalogued their shapes, growth patterns, and biochemical behavior. In 1885, he presented his findings to the Society of Morphology and Physiology in Munich, describing a rod-shaped organism he found abundantly in the lower gut, which he named “Bacterium coli commune.”1Nature Reviews Microbiology. In appreciation of Theodor Escherich
The Latin name was descriptive rather than grand: it simply meant “common colon bacterium.” Escherich noted the organism’s ability to ferment glucose, produce acid, and sour milk, properties that helped distinguish it from other microbes in the gut.2Oxford Academic. Escherichia Coli: What Is and Which Are? His detailed descriptions were a significant achievement for the era, when germ theory was still gaining acceptance and the tools for studying bacteria were rudimentary by modern standards. Escherich did not live to see how profoundly his discovery would influence science; he died in 1911. Eight years later, in 1919, the organism was formally renamed Escherichia coli in his honor.2Oxford Academic. Escherichia Coli: What Is and Which Are?
How a Gut Microbe Became Biology’s Favorite Organism
For decades after Escherich’s initial description, E. coli was known mainly as a common inhabitant of the mammalian intestine. Its transformation into the flagship organism of molecular biology happened in the 1940s, driven less by any single breakthrough than by a convergence of practical advantages. The bacterium grows quickly, doubles roughly every twenty minutes under good conditions, and thrives on cheap, simple growth media. Researchers in the emerging field of biochemical genetics realized that fundamental biological processes already documented in complex organisms, like enzyme regulation and genetic recombination, also occurred in bacteria. The simplicity of E. coli made these processes far easier to dissect.3Europe PMC. How Escherichia coli Became the Flagship Bacterium of Molecular Biology
This shift was not inevitable. Other bacteria could have filled the role. But once a critical mass of researchers adopted E. coli, a self-reinforcing cycle took hold: more tools were developed for it, which attracted more researchers, which led to more tools. By the mid-twentieth century, it was the default organism for asking basic questions about how life works at the molecular level.
Landmark Discoveries Made in E. Coli
The list of foundational biological discoveries made using E. coli reads like a highlight reel of twentieth-century science. In the 1940s, Salvador Luria and Max Delbrück used E. coli and its viruses (called bacteriophages) to demonstrate that bacterial mutations arise spontaneously rather than being induced by environmental pressure, a finding that earned them a Nobel Prize. Around the same time, Alfred Hershey, working with bacteriophages that infect E. coli, showed alongside Martha Chase that DNA, not protein, is the molecule that carries genetic information into cells.4PubMed. Escherichia coli and the Emergence of Molecular Biology
Joshua Lederberg’s work on bacterial recombination, also carried out in E. coli, revealed that bacteria could exchange genetic material, overturning the assumption that they reproduced in a strictly clonal fashion.5Europe PMC. Joshua Lederberg on Bacterial Recombination Then in 1961, François Jacob and Jacques Monod used the lac system in E. coli to develop the operon model, showing that genes are not simply read passively from DNA but are actively switched on and off by regulatory elements. Their framework of regulatory genes, operator sequences, and messenger RNA recast gene expression as a logic problem built on molecular decision circuits.6University of Ottawa Science Undergraduate Research Journal. L’ opéron lac : d’un modèle bactérien à un langage pour la régulation génique These discoveries collectively built the intellectual foundation of molecular biology, and all of them depended on the same humble gut bacterium.
How E. Coli First Colonizes the Human Body
E. coli is among the first bacteria to establish residence in a newborn’s intestine, but the timing depends on how the baby is delivered. Research examining meconium (the first stool a newborn passes) found no viable E. coli in samples from healthy neonates, regardless of whether they were delivered vaginally or by cesarean section. In vaginally delivered babies, colonization appeared on the second day of life, likely from exposure to the mother’s vaginal flora during birth. Babies born by cesarean section showed no E. coli colonization on the second or third day, confirming that the bacterium enters the gut after birth rather than being present before it.7PubMed Central. Prenatal versus Postnatal Initial Colonization of Healthy Neonates’ Colon Ecosystem by the Enterobacterium Escherichia coli
Once established, E. coli typically coexists peacefully with its host, consuming nutrients in the intestine and helping to crowd out genuinely harmful microbes. Not all early colonizing strains are equal, though. The B2 phylogenetic group, which includes both commensal and disease-causing strains, has been increasing in prevalence among E. coli populations that colonize infants shortly after birth, a trend that has drawn attention from researchers studying early-life gut health.8PubMed. Early settlers: which E. coli strains do you not want at birth?
When Harmless Strains Turn Dangerous
Most E. coli strains are completely harmless. A small fraction, however, have acquired the genetic tools to cause serious illness. The evolution of pathogenic strains is driven largely by horizontal gene transfer, a process where bacteria pick up new DNA from bacteriophages (viruses that infect bacteria), plasmids, or other mobile genetic elements. Through this mechanism, an originally harmless E. coli can gain virulence factors that let it invade tissues, evade the immune system, or produce toxins.9IntechOpen. Horizontal Gene Transfer and the Diversity of Escherichia coli
The most notorious example is Shiga toxin-producing E. coli (STEC), best known through the O157:H7 strain that has caused high-profile food contamination outbreaks. The primary weapon of STEC strains is the production of Shiga toxins, particularly types 1 and 2, which can damage the lining of the intestine and, in severe cases, cause kidney failure.10PubMed Central. Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization Research into how Shiga toxin crosses the intestinal wall has found that the toxin penetrates gut cells through a transcellular pathway, and the extent to which it manages to cross the intestinal barrier appears to be an important factor in determining how dangerous a particular STEC strain is for humans.11PubMed Central. Shiga toxin 2 translocation across intestinal epithelium is linked to virulence of Shiga toxin-producing Escherichia coli in humans
The genomic background of the bacterium matters too. Not every strain that picks up a virulence gene becomes a successful pathogen. The combination of newly acquired genes and the existing genetic context determines whether a strain evolves into something dangerous or fizzles out.
A Global Antibiotic-Resistant Clone
One of the more alarming chapters in E. coli‘s recent history involves sequence type 131 (ST131), a lineage that has spread worldwide and is now responsible for millions of drug-resistant infections each year, primarily urinary tract and bloodstream infections.12PubMed Central. Escherichia coli ST131: a multidrug-resistant clone primed for global domination ST131’s success is tied to a cocktail of traits: resistance to fluoroquinolones, production of extended-spectrum enzymes that break down cephalosporin antibiotics, a high load of virulence genes, and a particular variant of a surface adhesion molecule that helps it stick to urinary tract tissue.13PubMed Central. Global dissemination of a multidrug resistant Escherichia coli clone
Population genetics studies have traced the rise of ST131 back through several decades. The lineage consists of distinct subgroups, with clade C being the globally dominant one. The sequential acquisition of virulence and resistance genes on mobile genetic elements during the 1960s through the 1980s essentially loaded clade C for explosive success once conditions were right, and by the 1990s and 2000s, it had become the most predominant disease-causing E. coli lineage worldwide.14PubMed Central. Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131 A newer subclade, C1-M27, has been emerging particularly in Japan, adding further complexity to an already difficult public health problem.12PubMed Central. Escherichia coli ST131: a multidrug-resistant clone primed for global domination
The Surprisingly Vast E. Coli Gene Pool
One reason E. coli can be both a harmless gut resident and a deadly pathogen is the sheer scale of its genetic diversity. Any single E. coli cell carries roughly four to five thousand genes, but the species as a whole draws from a much larger shared pool. An early comparative analysis of 17 E. coli genomes found about 2,200 genes conserved across every isolate examined, while the total pan-genome, the complete catalog of all genes found in any E. coli strain, contained more than 13,000 genes.15PubMed Central. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates
More recent work, drawing on over 2,300 complete genomes, has refined the picture. The core genome shared by all strains sits around 2,400 genes, while the accessory genome (genes found in some strains but not others) adds another 5,200 or so.16PubMed Central. Decomposition of the pangenome matrix reveals a structure in gene distribution in the Escherichia coli species This means that any two E. coli strains plucked at random could differ by thousands of genes, a level of within-species variation that would be staggering in an animal. The model is described as an “open” pan-genome, meaning that sequencing additional strains continues to turn up genes never seen before.
The Water Quality Workhorse
Beyond laboratories and hospitals, E. coli plays a quiet but essential role in public health as the standard indicator of fecal contamination in water. Because it normally lives in the intestines of warm-blooded animals and does not persist well in the environment on its own, finding it in a water sample is treated as evidence of recent fecal pollution. Across the global water sector, E. coli remains the preferred microbial water quality indicator, and public health guidelines rely on its detection to assess whether drinking water is safe.17PubMed Central. The utility of Escherichia coli as a contamination indicator for rural drinking water: Evidence from whole genome sequencing This use dates back decades; the organism’s association with fecal contamination in surface waters has been reviewed and reaffirmed repeatedly since the mid-twentieth century.18Bacterial Indicators/Health Hazards Associated with Water. Escherichia coli: The Fecal Coliform
E. Coli as a Probiotic
The idea of deliberately swallowing E. coli for health benefits sounds counterintuitive, but it has a century-long track record. In the early twentieth century, the German physician Alfred Nissle isolated a particular E. coli strain from a soldier who remained healthy during a severe dysentery outbreak. That strain, now known as E. coli Nissle 1917, became the basis of a licensed pharmaceutical product still distributed in Germany and other countries today.19PubMed. Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties It is probably the most intensively researched probiotic E. coli strain in existence, and over the decades researchers have identified multiple mechanisms by which it supports gut health, from competing with harmful bacteria for nutrients and attachment sites to modulating the immune response.20PubMed Central. Insights from 100 Years of Research with Probiotic E. Coli
Engineering Insulin and Beyond
E. coli‘s most direct impact on everyday life may be its role as a living factory for producing human medicines. In the late 1970s, researchers successfully inserted a chemically synthesized human insulin gene into E. coli and coaxed the bacterium to produce the hormone. The first mammalian hormone expressed in bacteria was somatostatin, followed shortly by human insulin. By 1982, this bacterially produced human insulin had been approved for treating diabetes, providing the first practical and scalable alternative to insulin extracted from pig and cow pancreases.21PubMed Central. Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin
Today, recombinant human insulin is produced predominantly using E. coli and baker’s yeast, and work continues on engineering new host strains to improve yield and efficiency.22PubMed Central. Cell factories for insulin production Newer strains of E. coli have been specifically developed for greater efficiency in insulin production, with successful production runs at semi-technical scale.23PubMed. Expression and purification of recombinant human insulin from E. coli 20 strain Insulin was the proof of concept, but the same basic approach now produces a wide range of therapeutic proteins, industrial enzymes, and research reagents.
Watching Evolution in Real Time
One of the most celebrated experiments in modern biology uses E. coli to watch evolution happen. In 1988, Richard Lenski started growing twelve populations of E. coli under identical conditions, transferring them to fresh growth medium every day and freezing samples at regular intervals. The experiment is still running, with the populations now past 80,000 generations. After about 15 years, something remarkable happened in one of the twelve populations: the bacteria evolved the ability to consume citrate, a nutrient that was always present in the medium but that E. coli normally cannot use under those conditions. This new ability emerged through a series of mutations, and descendants of the citrate-eating cells eventually took over that population and diversified into new ecological roles.24PubMed Central. Innovation in an E. coli evolution experiment is contingent on maintaining adaptive potential until competition subsides
The Lenski experiment has become a landmark in evolutionary biology because the frozen samples act like a fossil record that can be revived and retested. Researchers can literally replay evolution from any earlier time point and ask whether the same innovations arise again. The citrate result showed that major evolutionary innovations can depend on the accumulation of seemingly neutral earlier mutations, a finding with implications far beyond bacteria.
Rewriting the Genetic Code Itself
The most radical recent chapter in the E. coli story involves synthetic biology efforts to rewrite its entire genome. In 2019, a team at Cambridge created a fully synthetic E. coli genome spanning four megabases, in which they replaced every occurrence of two sense codons and a stop codon with synonymous alternatives. The result was a viable organism whose genome used only 61 of the 64 possible codons, with 18,214 individual codons swapped out. The synthetic bacterium grew and reproduced, though somewhat more slowly than normal, and it allowed the deletion of a transfer RNA molecule that is otherwise essential.25PubMed Central. Total synthesis of Escherichia coli with a recoded genome
More recently, researchers have pushed further, creating an E. coli with a 57-codon genome, eliminating seven codons rather than three from the organism’s genetic vocabulary.26PubMed. Escherichia coli with a 57-codon genetic code These recoded organisms are not just intellectual exercises. Freeing up codons creates “blank slots” in the genetic code that can be repurposed to encode non-natural amino acids, potentially enabling the production of proteins with entirely new chemical properties. The approach also builds in a kind of genetic firewall: because viruses that infect normal E. coli rely on the standard genetic code, a recoded organism can resist viral infection, a valuable trait for industrial production.27Current Opinion in Systems Biology. Synthetic genomes with altered genetic codes
That a bacterium first isolated from the diapers of nineteenth-century Bavarian infants is now the chassis for rewriting the rules of life’s genetic code says something about the unpredictable trajectory of science. Escherich was trying to keep babies alive. What he found ended up reshaping our understanding of biology at every scale.